Skip to main content

ovarian cancer Archives

New lead for ovarian cancer treatment

Dec. 10, 2015—Combining inhibitors of the BMP signaling pathway with standard chemotherapy drugs may overcome drug resistance in ovarian cancer.

Read more


Drug combos enhance ovarian cancer cell death

Aug. 11, 2015—Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities.

Read more


VICC receives $100,000 ovarian cancer research grant

Jan. 21, 2014—The Kay Yow Cancer Fund, in partnership with the Women’s Basketball Coaches Association and The V Foundation for Cancer Research, has awarded a $100,000 ovarian cancer research grant to the Vanderbilt-Ingram Cancer Center.

Read more


Molecular circuits in ovarian cancer

Nov. 13, 2013—Vanderbilt researchers have used bioinformatics analysis of gene expression data to describe molecular “circuits” that drive ovarian cancer.

Read more


Overcoming resistance in ovarian cancer

Aug. 22, 2013—The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments.

Read more


Noted pediatric surgeon to deliver Brooks Lecture May 10

Apr. 18, 2013—Renowned pediatric surgeon, scientist and Harvard Medical School’s first female professor of surgery Patricia K. Donahoe will address the Section of Surgical Sciences’ 55th Barney Brooks Lecture, Friday, May 10, at 7 a.m. in 208 Light Hall.

Read more


A drug combo for ovarian cancer

Dec. 24, 2012—Combining another drug with platinum-based chemotherapies may be more effective against ovarian cancer.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more